Symptomtext
Pharmacist was administering dose of FLUZONE HD QIV where vaccine came out at base of needle instead of tip of needle with no reported adverse event; Initial information was received on 08-Dec-2023 regarding an unsolicited valid non-serious case received from a physician. This case involves an unknown age female patient to whom pharmacist administered dose of influenza quadrival A-B high dose HV vaccine [Fluzone high-dose quadrivalent] and came out of base of needle instead of tip of needle with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 08-Dec-2023, the patient received a 0.7 ml, total dose of suspect influenza quadrival A-B high dose HV vaccine (unknown formulation) (lot U8233AA, expiry date: 30-Jun-2024, strength: standard) via intramuscular route in left deltoid for Immunisation and pharmacist was administering dose of fluzone hd qiv where vaccine came out at base of needle instead of tip of needle with no reported adverse event (incorrect dose administered) (Latency: same day). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.